Tubulis

From Academic Start-Up to Multibillion-Dollar Acquisition

Gilead Sciences completed a $3.15 billion acquisition of Tubulis, an academic start-up co-founded by Prof. Christian Hackenberger, to commercialize its antibody-drug conjugate technology.